NCT04925336

Brief Summary

Evaluating the intraoperative pain is a major challenge for the anesthesia team. During anesthesia, changes in heart rate and blood pressure are interpreted qualitatively to evaluate the sympathetic response to nociceptive stimulation or the adaptation of analgesia during surgery. The new nociception monitors under development quantitatively explore other variables dependent on sympathetic activity or sympathetic / parasympathetic balance, such as the pulse wave amplitude measurement (Surgical Pleth Index (SPI index)), the pupil dilation reflex, respiratory sinus arrhythmia (ANI, Analgesia Nociception Index), or skin conductance index. Taken independently, these tools provide an assessment of nociception based on variations in the autonomic system, more robust than simply observing heart rate or blood pressure raw values. However, the relationship between variations in the neurovegetative system and pain can be compromised by various factors or intraoperative events such as hypovolemia, bleeding, certain sympathomimetic or sympatholytic treatments, the hypnosis depth, ventilation variation, fast filling, or body temperature. Moreover, investigators do not know the delay between the application of the painful stimulus and the observation of the variation of the different neurovegetative variables. This constitutes a limit of the practitioners' confidence in these monitoring tools. The nociception transmission pathways of to the vegetative centers and cortical areas are complex. Investigators hypothesis is that neurovegetative variations in response to nociceptive stimulation are not always associated with a cortical somatosensory response. In this project investigators investigate the relation between cortical (EEG) and vegetative reactions to acute and tonic nociceptive stimuli, as a preliminary step to apply these procedures to assess intraoperative reactions to nociceptive procedures in anesthetized patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2020

Completed
1.2 years until next milestone

Study Start

First participant enrolled

April 6, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 14, 2021

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 8, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 8, 2021

Completed
Last Updated

October 15, 2021

Status Verified

October 1, 2021

Enrollment Period

3 months

First QC Date

January 22, 2020

Last Update Submit

October 14, 2021

Conditions

Keywords

Nociceptive stimulationHealthy volunteerSimultaneous cortical activationNeuro-vegetative response

Outcome Measures

Primary Outcomes (1)

  • Simultaneous scheme of cortical activation and neuro-vegetative responses to controlled nociceptive stimuli

    Simultaneous scheme of cortical activation and neuro-vegetative responses secondary to controlled nociceptive stimuli will be defined as the occurrence of at least one among the following: * Changes of time-frequency distribution of the electroencephalographic activity during phasic or tonic pain stimulation, compared to a prior baseline period. * Recording of cortical evoked responses during phasic pain stimulation in a time latency range between 100-500 msec. * Changes in parasympathetic tone measured by Analgesia/Nociception Index (ANI) method (threshold of 50/100) during phasic or tonic stimulation * Recording of the skin conductance reflex (skin sympathetic response) during phasic or tonic stimulations

    Day 1

Secondary Outcomes (9)

  • EEG time-frequency analysis during phasic pain stimulation

    Day 1

  • Latency of evoked responses to phasic stimulation

    Day 1

  • Pick-to-pick amplitude of evoked responses to phasic stimulation

    Day 1

  • Quantification of skin sympathetic response during phasic stimulation

    Day 1

  • Qualitative Change of ANI Value during phasic stimulation

    Day 1

  • +4 more secondary outcomes

Study Arms (1)

Experimental

EXPERIMENTAL

Nociceptive intervention arm

Other: Nociceptive stimulation

Interventions

These investigations in healthy volunteers will study the association between cerebral and neurovegetative (sympathetic and parasympathetic) electrophysiological responses in response to a controlled and tolerable pain stimulus, determined for each individual. The pain stimulus will be delivered using an electrically conductive glove used in clinical practice for transcutaneous therapeutic stimulation. The thresholds of nociception and tolerance will be determined in each healthy volunteer.

Experimental

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteer over 18 years old
  • signed informed consent
  • affiliated to a social security

You may not qualify if:

  • Chronic pathology requiring chronic treatment
  • Cardiac rhythm disorders, pacemaker, cardiotropic treatment
  • Taking opioid analgesics during the previous week
  • Painful chronic, or migraine
  • Pathology of the hand, acrosyndrome, carpal tunnel syndrome
  • Pregnancy
  • People placed under protection of justice

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Neurologie Fonctionnelle et Epileptologie Hôpital Neurologique, GHE Hospices civils de Lyon

Bron, 69677, France

Location

MeSH Terms

Conditions

Nociceptive Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2020

First Posted

June 14, 2021

Study Start

April 6, 2021

Primary Completion

July 8, 2021

Study Completion

July 8, 2021

Last Updated

October 15, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations